Edema: all 840 studies

Page 2 of 9. Open to participants first (92), then studies with results posted, then the rest; newest registration first within each.

• Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium AssessmentCompletedNCT05411991Phase 4Results posted
• Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular EdemaCompletedNCT05343156Phase 2Results posted
• Restrictive Versus Liberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney InjuryTerminatedNCT05306964Not applicableResults posted
• A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.TerminatedNCT05063734Phase 2Results posted
• A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the RetinaCompletedNCT04976777Phase 3Results posted
• Foot and Ankle Post-operative Oedema Management Using Geko™CompletedNCT04927234Not applicableResults posted
• Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD)CompletedNCT04857996Phase 2Results posted
• Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein OcclusionCompletedNCT04812977Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein OcclusionCompletedNCT04740931Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein OcclusionCompletedNCT04740905Phase 3Results posted
• Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular EdemaCompletedNCT04739306Phase 3Results posted
• Evaluating Edema and Range of Motion Using Negative Pressure Therapy vs. Standard Surgical Dressing in Bilateral TKATerminatedNCT04712019Not applicableResults posted
• Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular EdemaTerminatedNCT04697758Phase 1/2Results posted
• A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)TerminatedNCT04611152Phase 3Results posted
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)TerminatedNCT04603937Phase 3Results posted
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)CompletedNCT04592419Phase 3Results posted
• A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal DystrophyCompletedNCT04498169Phase 2Results posted
• Transfoveal Micropulse Laser for Center Involving Diabetic Macular EdemaCompletedNCT04359771Phase 4Results posted
• Oral Sodium to Preserve Renal EfficiencY in Acute Heart FailureActive, not recruitingNCT04334668Not applicableResults posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular EdemaTerminatedNCT04292912Phase 1Results posted
• Compare the Diuretic Effect With Furosemide vs Furosemide and Albumin Combined in Cirrhotic PatientsTerminatedNCT04216784Phase 4Results posted
• Fingolimod as a Treatment of Cerebral Edema After Intracerebral HemorrhageCompletedNCT04088630Early Phase 1Results posted
• A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein OcclusionCompletedNCT04085341Phase 2Results posted
• To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular EdemaCompletedNCT04058067Phase 3Results posted
• Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular EdemaCompletedNCT03927690Phase 2Results posted
• Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaCompletedNCT03917472Phase 3Results posted
• Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)CompletedNCT03889444Results posted
• A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular EdemaCompletedNCT03866473Not applicableResults posted
• Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)CompletedNCT03739593Phase 2Results posted
• Sildenafil for Swimming-Induced Pulmonary Edema (SIPE) PreventionCompletedNCT03686813Phase 2Results posted
• Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFPCompletedNCT03675685Phase 1Results posted
• Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)CompletedNCT03632993Phase 2Results posted
• Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)CompletedNCT03610646Phase 3Results posted
• Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)CompletedNCT03526549Phase 3Results posted
• Micropulse for Suppression of Diabetic Macular EdemaCompletedNCT03519581Not applicableResults posted
• Effect of Acetazolamide on Subclinical High-Altitude Pulmonary Edema Detected by Lung UltrasonographyTerminatedNCT03490916Phase 4Results posted
• A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaCompletedNCT03481660Phase 3Results posted
• Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaCompletedNCT03481634Phase 3Results posted
• Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME)CompletedNCT03466099Phase 2Results posted
• Effectiveness and Safety of EN3835 in the Treatment of Cellulite in WomenCompletedNCT03446781Phase 3Results posted
• Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in WomenCompletedNCT03428750Phase 3Results posted
• A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular EdemaCompletedNCT03397264Phase 1/2Results posted
• Safety and Effectiveness of EN3835 in the Treatment of EFP in WomenCompletedNCT03329989Phase 2Results posted
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVOTerminatedNCT03203447Phase 3Results posted
• Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular EdemaCompletedNCT03126786Phase 2Results posted
• Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg LucentisCompletedNCT03097068Phase 4Results posted
• TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)CompletedNCT03093701Phase 2Results posted
• Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability StudyCompletedNCT03000283Phase 1Results posted
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVOTerminatedNCT02980874Phase 3Results posted
• Non-invasive Ventilation Versus Continuous Positive Airway Pressure in Cardiogenic Pulmonary EdemaCompletedNCT02977572Not applicableResults posted
• Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and SafetyCompletedNCT02953938Phase 4Results posted
• Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular EdemaCompletedNCT02949024Phase 1/2Results posted
• EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)CompletedNCT02942160Phase 2Results posted
• Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)CompletedNCT02914613Phase 1/2Results posted
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric InfarctionTerminatedNCT02864953Phase 3Results posted
• MIdazolam Versus MOrphine in Acute Pulmonary Edema (MIMO Trial)TerminatedNCT02856698Phase 4Results posted
• Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)CompletedNCT02818998Phase 3Results posted
• EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)CompletedNCT02724644Phase 2Results posted
• Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular EdemaCompletedNCT02712008Phase 2Results posted
• A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular EdemaCompletedNCT02699450Phase 2Results posted
• A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)CompletedNCT02698566Phase 3Results posted
• Influence of Diabetes Control on Treatment of Diabetic Macular Edema With RanibizumabTerminatedNCT02665689Phase 4Results posted
• Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) StudyCompletedNCT02661711Phase 2Results posted
• Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy TrialCompletedNCT02623426Phase 3Results posted
• Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.CompletedNCT02581995Phase 4Results posted
• Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.CompletedNCT02571972Phase 2Results posted
• Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or BevacizumabCompletedNCT02559180Phase 4Results posted
• Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVOCompletedNCT02503540Phase 4Results posted
• Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular EdemaCompletedNCT02471651Phase 4Results posted
• Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)TerminatedNCT02460874Phase 1/2Results posted
• The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid ExudatesCompletedNCT02448446Phase 1/2Results posted
• Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior ChemotherapyActive, not recruitingNCT02411656Phase 2Results posted
• Third Molar Extraction and Pulsed Electromagnetic FieldTherapyTerminatedNCT02376946Not applicableResults posted
• PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema TrialCompletedNCT02374060Phase 3Results posted
• Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular EdemaCompletedNCT02348918Phase 2Results posted
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVOCompletedNCT02303184Phase 2Results posted
• Can Vena Cava Ultrasound Guided Volume Repletion Prevent Spinal Induced Significant Hypotension in Elective Patients?CompletedNCT02271477Not applicableResults posted
• Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DMECompletedNCT02262260Phase 3Results posted
• A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) PatientsCompletedNCT02259088Phase 3Results posted
• Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious UveitisCompletedNCT02255032Phase 2Results posted
• Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular EdemaCompletedNCT02245516Not applicableResults posted
• Near Infrared Photobiomodulation Treatment for Diabetic Macular OedemaCompletedNCT02181400Not applicableResults posted
• A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular EdemaCompletedNCT02121262Phase 3Results posted
• Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled TrialCompletedNCT02055872Phase 3Results posted
• Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular EdemaCompletedNCT02036424Phase 4Results posted
• Clinical Efficacy of Bevacizumab Combined With Navigated Laser in Patients With Clinically Significant Macula EdemaTerminatedNCT02032238Not applicableResults posted
• Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment PhaseTerminatedNCT02032173Phase 3Results posted
• Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVOCompletedNCT02006147Phase 1/2Results posted
• A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular EdemaTerminatedNCT01994291Phase 2Results posted
• A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic PanniculopathyCompletedNCT01987986Phase 2Results posted
• Safety and Efficacy of Ranibizumab for Diabetic Macular EdemaCompletedNCT01982435Phase 1/2Results posted
• Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)CompletedNCT01976338Phase 3Results posted
• Diabetic Macular Edema Treated With Ozurdex (DMEO)CompletedNCT01951066Phase 2Results posted
• Phase II Combination Steroid and Anti-VEGF for Persistent DMECompletedNCT01945866Phase 2Results posted
• A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular EdemaCompletedNCT01934556Phase 1/2Results posted
• Treatment for CI-DME in Eyes With Very Good VA StudyCompletedNCT01909791Phase 3Results posted
• Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg DexamethasoneCompletedNCT01892163Phase 3Results posted
• OCT Screening for Diabetic Macular Edema at Primary Diabetes Care VisitsCompletedNCT01875783Not applicableResults posted
• To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular EdemaCompletedNCT01846299Phase 3Results posted
• A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema.CompletedNCT01821677Phase 2Results posted

← Edema overview